IL128940A0 - C-terminal modified (n-substituted)-2-indolyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases and pharmaceutical compositions containing them - Google Patents

C-terminal modified (n-substituted)-2-indolyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases and pharmaceutical compositions containing them

Info

Publication number
IL128940A0
IL128940A0 IL12894097A IL12894097A IL128940A0 IL 128940 A0 IL128940 A0 IL 128940A0 IL 12894097 A IL12894097 A IL 12894097A IL 12894097 A IL12894097 A IL 12894097A IL 128940 A0 IL128940 A0 IL 128940A0
Authority
IL
Israel
Prior art keywords
ced
ice
substituted
pharmaceutical compositions
dipeptides
Prior art date
Application number
IL12894097A
Other languages
English (en)
Original Assignee
Idun Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/767,175 external-priority patent/US5869519A/en
Application filed by Idun Pharmaceuticals Inc filed Critical Idun Pharmaceuticals Inc
Publication of IL128940A0 publication Critical patent/IL128940A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
IL12894097A 1996-09-12 1997-09-12 C-terminal modified (n-substituted)-2-indolyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases and pharmaceutical compositions containing them IL128940A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2601196P 1996-09-12 1996-09-12
US08/767,175 US5869519A (en) 1996-12-16 1996-12-16 C-terminal modified (n-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
PCT/US1997/016157 WO1998011129A1 (en) 1996-09-12 1997-09-12 C-TERMINAL MODIFIED (N-SUBSTITUTED)-2-INDOLYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES

Publications (1)

Publication Number Publication Date
IL128940A0 true IL128940A0 (en) 2000-02-17

Family

ID=26700600

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12894097A IL128940A0 (en) 1996-09-12 1997-09-12 C-terminal modified (n-substituted)-2-indolyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases and pharmaceutical compositions containing them

Country Status (11)

Country Link
EP (1) EP0920444B1 (xx)
JP (1) JP3492703B2 (xx)
KR (1) KR20000036056A (xx)
CN (1) CN1234038A (xx)
AT (1) ATE229973T1 (xx)
AU (1) AU739321B2 (xx)
CA (1) CA2265928A1 (xx)
DE (1) DE69718012T2 (xx)
IL (1) IL128940A0 (xx)
NZ (1) NZ334605A (xx)
WO (1) WO1998011129A1 (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610683B2 (en) * 1996-09-12 2003-08-26 Idun Pharmaceuticals, Inc. Treatment of infectious disease using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors
EP1062210B1 (en) 1998-03-09 2005-06-01 Vertex Pharmaceuticals Incorporated 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors
PT1064298E (pt) * 1998-03-19 2009-01-02 Vertex Pharma Inibidores de caspasas
AU3866799A (en) * 1998-05-04 1999-11-23 Zymogenetics Inc. Cytoplasmic antiproteinase-3 coding sequence in gene therapy
SK13922002A3 (sk) 2000-03-29 2003-09-11 Vertex Pharmaceuticals Incorporated Karbamátové inhibítory kaspázy a ich použitie
PE20011350A1 (es) 2000-05-19 2002-01-15 Vertex Pharma PROFARMACO DE UN INHIBIDOR DE ENZIMA CONVERTIDORA DE INTERLEUCINA-1ß (ICE)
JP4349802B2 (ja) 2000-11-21 2009-10-21 バーテックス ファーマシューティカルズ インコーポレイテッド イミダゾールおよびベンゾイミダゾールカスパーゼのインヒビターならびにそれらの使用
AU2002245649A1 (en) * 2001-03-02 2002-09-19 Idun Pharmaceuticals, Inc. Methods, compositions and kits for preserving antigenicity
WO2002085899A1 (en) 2001-04-19 2002-10-31 Vertex Pharmaceuticals Incorporated Heterocyclyldicarbamides as caspase inhibitors
US7297714B2 (en) * 2003-10-21 2007-11-20 Irm Llc Inhibitors of cathepsin S
KR20060129069A (ko) * 2004-02-27 2006-12-14 버텍스 파마슈티칼스 인코포레이티드 카스파제 억제제 및 이의 용도
SI2399915T1 (sl) 2004-03-12 2015-05-29 Vertex Pharmaceuticals Incorporated Postopek in intermediati za pripravo inhibitorjev asparagin-acetal-kaspaze
GB0411056D0 (en) 2004-05-18 2004-06-23 Novartis Ag Organic compounds
ATE529430T1 (de) 2005-07-28 2011-11-15 Vertex Pharma Caspase-hemmer-propharmaka
JP5183907B2 (ja) * 2006-11-07 2013-04-17 株式会社パーマケム・アジア ペリンドプリルの前駆体の製造方法、及び、ペリンドプリルエルブミンの製造方法と精製方法
US9956260B1 (en) 2011-07-22 2018-05-01 The J. David Gladstone Institutes Treatment of HIV-1 infection and AIDS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5514694A (en) * 1992-09-21 1996-05-07 Georgia Tech Research Corp Peptidyl ketoamides
US5486623A (en) * 1993-12-08 1996-01-23 Prototek, Inc. Cysteine protease inhibitors containing heterocyclic leaving groups
US5498616A (en) * 1994-11-04 1996-03-12 Cephalon, Inc. Cysteine protease and serine protease inhibitors
US5843904A (en) * 1995-12-20 1998-12-01 Vertex Pharmaceuticals, Inc. Inhibitors of interleukin-1βconverting enzyme

Also Published As

Publication number Publication date
AU4413897A (en) 1998-04-02
ATE229973T1 (de) 2003-01-15
EP0920444B1 (en) 2002-12-18
AU739321B2 (en) 2001-10-11
CA2265928A1 (en) 1998-03-19
WO1998011129A1 (en) 1998-03-19
DE69718012D1 (de) 2003-01-30
KR20000036056A (ko) 2000-06-26
NZ334605A (en) 2000-08-25
CN1234038A (zh) 1999-11-03
EP0920444A1 (en) 1999-06-09
JP3492703B2 (ja) 2004-02-03
DE69718012T2 (de) 2003-09-25
JP2001501923A (ja) 2001-02-13

Similar Documents

Publication Publication Date Title
MXPA00013014A (es) Dipe`tidos de oxamilos modificados en el extremo carboxi como inhibidores de la familia ice/ced-3 de proteasas de cisteinas.
BR0008584A (pt) 2-indolil(n-substituìdo)carbonildipeptìdeos modificados no terminal c como inibidores da famìlia ice/ced-3 das cisteìna proteases
IL128940A0 (en) C-terminal modified (n-substituted)-2-indolyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases and pharmaceutical compositions containing them
SG158733A1 (en) Cell adhesion inhibitors
WO2003072528A3 (en) (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
NO20011968L (no) (Substituerte)acyl dipeptidyl-inhibitorer av ICE/ced-3 familien av cysteinproteaser
WO1992011850A3 (en) Use of calpain inhibitors in the inhibition and treatment of neurodegeneration
MX9705569A (es) Inhibidores de adhesion celular.
MX9800348A (es) Inhibidores de adhesion celular.
NZ335981A (en) Ketobenzamides as calpain inhibitors
IL116078A (en) Substituted heterocyclic compounds capable of inhibiting serine proteases and pharmaceutical compositions containing them
IL122116A0 (en) Polypeptide comprising kunitz-type serine protease inhibitor
HUP0000492A1 (hu) N-(Aril/heteroaril-acetil)-aminosav-észterek, azokat tartalmazó gyógyászati készítmények, valamint módszerek béta-amiloid fehérje képződése és felszabadulása gátlására e vegyületek felhasználásával
EA200100872A1 (ru) Композиция валдекоксиба
AU4583597A (en) Novel tricyclic compounds for the inhibition of the ice/ced-3 protease family of enzymes
ZA951974B (en) Bradykinin antagonist peptides incorporating N-subsituted glycines
WO2002057298A3 (en) C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases
MX9403088A (es) Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso.
HUP9901353A2 (hu) ACE-inhibitorok alkalmazása diszpepsziás tünetek kezelésére alkalmas gyógyszerkészítmény előállítására
DE60108495D1 (en) Thrombin inhibitoren
WO2001079162A3 (en) INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES
DE50002304D1 (en) Tyrosin- und tryptophanhaltige peptide als antioxidantien
ES2131468A1 (es) Uso de la melatonina en el tratamiento de las enfermedades neurodegenerativas.
ATE189391T1 (de) Verwendung von lithiumverbindungen zur behandlung und prophylaxe des morbus alzheimer